ORAL SEMAGLUTIDE VERSUS EMPAGLIFLOZIN, SITAGLIPTIN AND LIRAGLUTIDE IN THE UK: LONG-TERM COST-EFFECTIVENESS ANALYSES BASED ON THE PIONEER CLINICAL TRIAL PROGRAMME

Descargar Publicación
Metformin in colorectal cancer: molecular mechanism, preclinical and clinical aspects Risk Factors of Metabolic Syndrome Among Patients Receiving Antipsychotics: A Retrospective Study